1. Home
  2. VNCE vs XLO Comparison

VNCE vs XLO Comparison

Compare VNCE & XLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VNCE
  • XLO
  • Stock Information
  • Founded
  • VNCE 2002
  • XLO 2016
  • Country
  • VNCE United States
  • XLO United States
  • Employees
  • VNCE N/A
  • XLO 73
  • Industry
  • VNCE Clothing/Shoe/Accessory Stores
  • XLO Biotechnology: Pharmaceutical Preparations
  • Sector
  • VNCE Consumer Discretionary
  • XLO Health Care
  • Exchange
  • VNCE Nasdaq
  • XLO Nasdaq
  • Market Cap
  • VNCE 37.1M
  • XLO 38.5M
  • IPO Year
  • VNCE 2013
  • XLO 2021
  • Fundamental
  • Price
  • VNCE $2.91
  • XLO $0.76
  • Analyst Decision
  • VNCE Strong Buy
  • XLO Buy
  • Analyst Count
  • VNCE 4
  • XLO 2
  • Target Price
  • VNCE $4.63
  • XLO $3.00
  • AVG Volume (30 Days)
  • VNCE 434.1K
  • XLO 402.0K
  • Earning Date
  • VNCE 12-09-2025
  • XLO 11-06-2025
  • Dividend Yield
  • VNCE N/A
  • XLO N/A
  • EPS Growth
  • VNCE N/A
  • XLO N/A
  • EPS
  • VNCE N/A
  • XLO N/A
  • Revenue
  • VNCE $291,286,000.00
  • XLO $15,001,000.00
  • Revenue This Year
  • VNCE $1.48
  • XLO $519.70
  • Revenue Next Year
  • VNCE $4.92
  • XLO $44.57
  • P/E Ratio
  • VNCE N/A
  • XLO N/A
  • Revenue Growth
  • VNCE N/A
  • XLO 536.45
  • 52 Week Low
  • VNCE $1.02
  • XLO $0.62
  • 52 Week High
  • VNCE $6.89
  • XLO $1.70
  • Technical
  • Relative Strength Index (RSI)
  • VNCE 52.21
  • XLO 47.59
  • Support Level
  • VNCE $2.62
  • XLO $0.74
  • Resistance Level
  • VNCE $3.21
  • XLO $0.81
  • Average True Range (ATR)
  • VNCE 0.26
  • XLO 0.05
  • MACD
  • VNCE -0.07
  • XLO -0.01
  • Stochastic Oscillator
  • VNCE 38.20
  • XLO 18.54

About VNCE Vince Holding Corp.

Vince Holding Corp is a fashion brand that is engaged in wholesale and retail delivery of luxury essentials like women's and men's apparel, women's and men's footwear, and handbags. Its offers women's collections of luxurious cashmere sweaters and silk blouses, leather and suede leggings and jackets, dresses, denim, pants, tanks and t-shirts, and a growing assortment of outerwear. It focuses on developing an elevated collection of Vince apparel and accessories to serve the luxurious need of the customer. The company manages its business in three segments namely Vince Wholesale, Vince Direct-to-consumer, and Rebecca Taylor and Parker segment. It operates its e-commerce business through its website. Majority of its revenue generated from Vince Wholesale segment.

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies (including bispecifics) and immune cell engagers (including tumor-activated cell engagers and tumor-activated effector-enhanced cell engagers).

Share on Social Networks: